← Portfolio
P
PracticeFlow

Revenue Cycle Benchmarking

Compare your practice KPIs against 80 synthetic peer cohort practices · Modeled on MGMA & HFMA published benchmarks

Your Practice Metrics
Days in A/R
36
Denial Rate %
5.8
Collection Rate %
94.2
Avg Reimb. ($)
295
No-Show Rate %
9.1
Days in A/R
36 days
Your Percentile
66th
23.7 days▲ You: 36 days43.5 days
Denial Rate
5.8%
Your Percentile
56th
3.5%▲ You: 5.8%7.4%
Collection Rate
94.2%
Your Percentile
94th
88.4%▲ You: 94.2%94.4%
Avg Reimbursement ($)
295
Your Percentile
54th
243.0▲ You: 295326.0
No-Show Rate
9.1%
Your Percentile
84th
5.0%▲ You: 9.1%10.9%
Peer Cohort Percentiles — Dermatology · Small (2-5)
Metric25th50th (Median)75thYour Valuevs Median
Days in A/R28.533.838.136 2.2 worse
Denial Rate4.6%5.6%6.5%5.8% 0.2 worse
Collection Rate90.0%91.0%92.8%94.2% 3.2 above
Avg Reimbursement263.5293.5306.3295 1.5 above
No-Show Rate6.4%7.6%8.5%9.1% 1.5 worse
Days in A/R — 12-Month Trend
JulAugSepOctNovDecJanFebMarAprMayJun
Denial Rate — 12-Month Trend
JulAugSepOctNovDecJanFebMarAprMayJun
Diagnostic Drill — What's Driving Your Days in A/R
Your A/R: 36 days · Predicted from drivers: 33.7 days

Days in A/R is a downstream metric — the sum of four upstream drivers. Knowing you're at the 34th percentile is the easy diagnosis; identifying which lever to pull is the consultative one. Adjust your payer mix and denial-resubmission cycle below to see how the components decompose.

Commercial Payer Mix
55%
~25-day cycle (clean)
Gov Payer Mix (Medicare + Medicaid)
30%
~32-day FFS cycle · patient-pay auto = 15%
Denial Resubmission Cycle (days)
14d
Industry best-practice: 7d
Where Your A/R Days Come From
13.8d
9.6d
9.8d
Commercial payer mix · 13.8d · 55% of revenue at ~25-day clean-claim cycle
Gov (Medicare/Medicaid) · 9.6d · 30% at ~32-day FFS cycle
Patient-pay aging · 9.8d · 15% at ~65-day self-pay aging
Denial cycle drag · 0.6d · 5.8% denial × 14d resubmission
Unexplained process drag · 2.3d · Eligibility, posting, follow-up cadence
Highest-Leverage Intervention
Patient-pay collection program (~2.8d recovery)

15% → 8% patient AR via point-of-service collection + financing options.

Other levers in order: Tighten back-office process drag (~1.4d)

Data Note: Benchmarks generated from synthetic practice data modeled on published MGMA, HFMA, and CMS cost report distributions for Dermatology practices of size Small (2-5). Not sourced from real practice data. Adjust "Your Practice Metrics" sliders to see where a practice would rank against the peer cohort. Diagnostic Drill anchors (commercial 25d / gov 32d / patient 65d / resubmission 7d best-practice) are published industry medians; production deployments would calibrate these against the practice's own billing system.